BridgeMD
Compares treatment options for Shoulder Frozen
Official title Compare the Effect of Spencer Technique With and Without AC Mobilization for FS Pathients
ClinicalTrials.gov ID: NCT06763679
What this study is testing
- What it's testing
- The propose of the study will help the clinicians provide an evidence-based approach for the application of Spencer technique and acromioclavicular mobilization, an application of these techniques on pain, range of motion and functional disability of patients of frozen shoulder. So, that it can be determined which treatment is superior in terms of achieving better results in the management regime.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 50 to 60
You may be able to join if
- Male and female both are included
- Age of 50-60 years
- Unilateral frozen shoulder stage 2 with pain lasting for more than 1 month
- Capsular pattern of motion restriction (lateral rotation, abduction, medial rotation)
- More than 50% loss of passive movement of shoulder
You likely can't join if
- Rotator cuff tear
- Dislocation of shoulder
- Shoulder subluxation
- Upper limb fracture
- History of shoulder surgery
- All other co-morbidities are excluded
The study team makes the final eligibility decision.
Where it's taking place
- Lahore, Punjab Province, Pakistan
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 50 years to 60 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Lahore, Punjab Province, Pakistan. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.